VENTURE EQUITY FUND

FUND SUMMARY

The Venture Equity Fund invests in early-stage technologies poised to capitalize on the paradigm shifts in healthcare. The coming decade will bring burgeoning opportunities as entrepreneurs strive to reduce costs and improve the quality of care and services. Adaptive Health Capital offers Portfolio Companies “smart money”: investment accompanied by active oversight, dedicating mentoring, and unmatched access to a big network of healthcare leadership from all walks of industry.

The Venture Equity Fund capitalizes on hundreds of “first look” investment opportunities that Adaptive Heath Capital’s founders receive in early-stage healthcare companies, focusing on the niche between the angel investment “seed” stage and venture capital “Series A” investment stage. Often referred to as a “Valley of Death” where healthcare entrepreneurs have become revenue-positive but struggle and founder before becoming cash flow-positive, Adaptive Health Capital sees a unique chance to support promising investment-worthy opportunities beyond seed and before exit. In doing do, the Fund seeks to infuse genuine value as active investors. The focus is on business-to-business companies that recognize and are positioned to seize upon paradigm shifts in healthcare, including the “outpatient-ification” of healthcare services and the shift from volume-based to value-based models. The Venture Equity Fund focuses on companies in four principal verticals:

  • Aging in Place technologies
  • Telemedicine
  • Digital Health
  • Care Coordination

Adaptive Health Capital seeks companies in these verticals that are well-positioned to take maximal advantage of dramatic improvements in the precision of care delivery services through biomedical research, healthcare information technology, and informatics. While other funds hunt for the “home run” on the rare “unicorn,” the Venture Equity Fund seeks to take advantage of “singles” and “doubles,” i.e. more modest but nonetheless profitable healthcare investment opportunities.

Adaptive Healthcare Fund Announces Investment in Asynchronous Telehealth Provider Lemonaid Health

Adaptive Healthcare participates in Lemonaid Health’s investment round enabling scaling
“Our goal is to identify and invest in opportunities driven by paradigm shifts in healthcare. Adaptive is excited to share exciting news on our forthcoming portfolio investments.”

LOS ANGELES, CA (PRWEB) MAY 24, 2017
Adaptive Healthcare, the first Southern California-based investment fund focusing on opportunities driven by healthcare transformation, has announced the second portfolio investment of its LaunchPad Fund in Lemonaid Health, a fast-growing provider of asynchronous telehealth services. Adaptive Healthcare joined Novartis Venture Fund, Hikma Ventures, Correlation Ventures, Vega Ventures, and 415 Ventures as part of an $11 million funding round.
Led by founders Ian Van Every and Paul Johnson, Lemonaid is a national leader in expanding the utilization of asynchronous telehealth, employing an innovative technology platform embedded with expert clinical protocols to provide low cost, high quality, easy-to-use telehealth solutions. Lemonaid presently treats a variety of common conditions, including UTI, flu, sinus, acid reflux, acne, erectile dysfunction, and hair loss, and is expanding to treat a broader range of conditions.
“Lemonaid Health’s brilliant leadership team and its record to date made this a compelling investment,” commented Adaptive Healthcare’s Fund Manager, Larry Gill. “We think Lemonaid’s team has cracked the code on a scalable telehealth model.” Harry Nelson, co-chair of Adaptive’s Investment committee and co-author of From ObamaCare to TrumpCare: Why You Should Care commented: “Our healthcare system currently suffers from the unfortunate trifecta of high cost, low quality, and inconvenient, poor patient experience. Lemonaid’s standardization, focused treatment offerings, and process efficiency solve all three problems in one strike, an irresistible combination that has eluded other telehealth companies.”
In connection with the investment of $1m, Adaptive Healthcare will provide advisory support to the company, consistent with its value proposition of offering “smart money,” including input on strategy and connecting the company with Adaptive’s network of leadership from all walks of the healthcare industry. “The advice of the Adaptive team has been invaluable,” said co-CEO Ian Van Every. “The group’s support and insight has already helped us attract significant additional funding, which we will be announcing in the near future.”
Adaptive Healthcare launched in 2016 with two funds, the LaunchPad Fund, which invests in early-stage technologies poised to capitalize on the paradigm shifts in healthcare, including aging in place technologies, digital health, telehealth, and care coordination, and the Expansionary fund offering debt funding to catalyze growth in mature healthcare companies. “Our goal,” commented Investment Committee Co-Chair Rob Fuller, is to “identify and invest in opportunities driven by paradigm shifts in healthcare. Adaptive is excited to share exciting news on our forthcoming portfolio investments.”

Adaptive Healthcare Fund Announces Investment in Care Coordination Technology Provider LifeAssist

Adaptive Healthcare’s investment will enable LifeAssist Technologies to enhance its software platform, expand pilots, and develop strategic partnerships.
LifeAssist represents a breakthrough solution for care transitions and coordination, by offering unprecedented efficiency in enabling complex layers of information to be shared and distributed.

LOS ANGELES, CA (PRWEB) MARCH 28, 2017
Adaptive Healthcare, the first Southern California-based investment fund focusing on opportunities driven by healthcare transformation, has announced the first portfolio investment of its LaunchPad Fund in LifeAssist Technologies.
LifeAssist, which is led by co-founder and CEO Val Ornoy, integrates its pioneering enterprise software platform with a low-cost in-home device to coordinate care and streamline communication and collaboration between caregivers, families, and health professionals. Whether the “care circle” initiates in the hospital , nursing home, or when a patient is already home, LifeAssist enables the care team to be organized and communicate efficiently, allowing for an unprecedented level of ease in getting the right information where it needs to go, as well as allowing family members to know the relevant details that they worry about: did a caregiver arrive on time? Were meals eaten and medication taken in real time as care was being delivered? The in-home device enable easy two-way communication, serving as a portal for in-home caregivers and the person at the center of care circle.
“We are excited to make this investment in LifeAssist,” commented Adaptive Healthcare’s Fund Manager, Larry Gill. “LifeAssist represents a breakthrough solution for care transitions and coordination, by offering unprecedented efficiency in enabling complex layers of information to be shared and distributed. We believe it represents key ‘connective tissue’ that is missing from the healthcare landscape.“
In connection with the investment, Adaptive Healthcare Investment Committee co-chair Harry Nelson has joined the advisory board of LifeAssist, providing ongoing support to the company. This type of support is at the core of the Adaptive Healthvcare vision of providing “smart money,” meaning investment accompanied by dedicating mentoring, input on strategy, and connecting the company with Adaptive’s network of leadership from all walks of the healthcare industry. “Working with the LifeAssist team has only reinforced our conviction that its solution represents a significant breakthrough. We love the team, the product, ad the product-market fit,” commented Nelson. “Given the uncertainty ahead over the availability of healthcare reimbursement for care coordination, the need for value-driven solutions is compelling. We see LifeAssist’s technology as an important piece of the puzzle.”
“The funding and advisory support of Adaptive Healthcare has been a game-changer for our company,” said LifeAssist CEO Val Ornoy. “It has led us to broaden our thinking about applications for our device, to pursue promising strategic partnerships, and has also made us more attractive to other outside investors.”
Adaptive Healthcare launched in 2016 with two funds. Adaptive Healthcare’s LaunchPad Fund invests in early-stage technologies poised to capitalize on the paradigm shifts in healthcare, including aging in place technologies, digital health, telehealth, and care coordination, as entrepreneurs strive to reduce costs and improve the quality of care and services. In addition, Adaptive’s Expansionary fund efforts debt funding intended to catalyze growth in mature healthcare companies. “Our goal,” commented Investment Committee Co-Chair Rob Fuller, is to “identify and invest in opportunities driven by paradigm shifts in healthcare. Adaptive is in the process of finalizing additional portfolio investments, which we look forward to sharing in the near future.”